Ming Yan - Jul 22, 2021 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Technology Officer, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Ming Yan
Stock symbol
CTKB
Transactions as of
Jul 22, 2021
Transactions value $
$0
Form type
4
Date filed
7/26/2021, 09:53 PM
Next filing
Feb 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Stock Option (Right to Buy) Award $0 +125K $0.00 125K Jul 22, 2021 Common Stock 125K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 22, 2022; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.